Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1Stéphane Champiat, Charles Ferté, Antoine Hollebecque et al.|Clinical Cancer Research|2016Cited by 1.2k
Evaluation of the efficacy of immunotherapy for non-resectable mucosal melanomaAntoine Moya‐Plana, Caroline Robert, Ruth Gabriela Herrera Gómez et al.|Cancer Immunology Immunotherapy|2019Cited by 89